A variation in 3 ' UTR of hPTP1B increases specific gene expression and associates with insulin resistance
(2002) In American Journal of Human Genetics 70(3). p.806-812- Abstract
- Protein tyrosine phosphatase 1B (PTP1B) inhibits insulin signaling and, when overexpressed, plays a role in insulin resistance (Ahmad et al. 1997). We identified, in the 3' untranslated region of the PTP1B gene, a 1484insG variation that, in two different populations, is associated with several features of insulin resistance: among male individuals, higher values of the insulin resistance HOMA(IR) index (P = .006), serum triglycerides (P = .0002), and total/HDL cholesterol ratio (P = .025) and, among female individuals, higher blood pressure (P = .01). Similar data were also obtained in a family-based association study by use of sib pairs discordant for genotype (Gu et al. 2000). Subjects carrying the 1484insG variant showed also PTP1B... (More)
- Protein tyrosine phosphatase 1B (PTP1B) inhibits insulin signaling and, when overexpressed, plays a role in insulin resistance (Ahmad et al. 1997). We identified, in the 3' untranslated region of the PTP1B gene, a 1484insG variation that, in two different populations, is associated with several features of insulin resistance: among male individuals, higher values of the insulin resistance HOMA(IR) index (P = .006), serum triglycerides (P = .0002), and total/HDL cholesterol ratio (P = .025) and, among female individuals, higher blood pressure (P = .01). Similar data were also obtained in a family-based association study by use of sib pairs discordant for genotype (Gu et al. 2000). Subjects carrying the 1484insG variant showed also PTP1B mRNA overexpression in skeletal muscle (6,166 +/- 1,879 copies/40 ng RNA vs. 2,983 +/- 1,620;). Finally, PTP1B mRNA stability was significantly higher (P < .01) in human embryo kidney 293 cells transfected with 1484insG PTP1B, as compared with those transfected with wild-type PTP1B. Our data indicate that the 1484insG allele causes PTP1B overexpression and plays a role in insulin resistance. Therefore, individuals carrying the 1484insG variant might particularly benefit from PTP1B inhibitors, a promising new tool for treatment of insulin resistance (Kennedy and Ramachandran 2000). (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/343595
- author
- organization
- publishing date
- 2002
- type
- Contribution to journal
- publication status
- published
- subject
- in
- American Journal of Human Genetics
- volume
- 70
- issue
- 3
- pages
- 806 - 812
- publisher
- Cell Press
- external identifiers
-
- pmid:11833006
- wos:000173880000026
- scopus:0036008643
- ISSN
- 0002-9297
- DOI
- 10.1086/339270
- language
- English
- LU publication?
- yes
- id
- b5610a8d-3bed-4276-ab4a-a13265391531 (old id 343595)
- date added to LUP
- 2016-04-01 12:27:25
- date last changed
- 2024-02-24 09:20:00
@article{b5610a8d-3bed-4276-ab4a-a13265391531, abstract = {{Protein tyrosine phosphatase 1B (PTP1B) inhibits insulin signaling and, when overexpressed, plays a role in insulin resistance (Ahmad et al. 1997). We identified, in the 3' untranslated region of the PTP1B gene, a 1484insG variation that, in two different populations, is associated with several features of insulin resistance: among male individuals, higher values of the insulin resistance HOMA(IR) index (P = .006), serum triglycerides (P = .0002), and total/HDL cholesterol ratio (P = .025) and, among female individuals, higher blood pressure (P = .01). Similar data were also obtained in a family-based association study by use of sib pairs discordant for genotype (Gu et al. 2000). Subjects carrying the 1484insG variant showed also PTP1B mRNA overexpression in skeletal muscle (6,166 +/- 1,879 copies/40 ng RNA vs. 2,983 +/- 1,620;). Finally, PTP1B mRNA stability was significantly higher (P < .01) in human embryo kidney 293 cells transfected with 1484insG PTP1B, as compared with those transfected with wild-type PTP1B. Our data indicate that the 1484insG allele causes PTP1B overexpression and plays a role in insulin resistance. Therefore, individuals carrying the 1484insG variant might particularly benefit from PTP1B inhibitors, a promising new tool for treatment of insulin resistance (Kennedy and Ramachandran 2000).}}, author = {{Di Paola, R and Frittitta, L and Miscio, G and Bozzali, M and Baratta, R and Centra, M and Spampinato, D and Santagati, MG and Ercolino, T and Cisternino, C and Soccio, T and Mastroianno, S and Tassi, V and Almgren, Peter and Pizzuti, A and Vigneri, R and Trischitta, V}}, issn = {{0002-9297}}, language = {{eng}}, number = {{3}}, pages = {{806--812}}, publisher = {{Cell Press}}, series = {{American Journal of Human Genetics}}, title = {{A variation in 3 ' UTR of hPTP1B increases specific gene expression and associates with insulin resistance}}, url = {{http://dx.doi.org/10.1086/339270}}, doi = {{10.1086/339270}}, volume = {{70}}, year = {{2002}}, }